Reviews: Current Topics
Anti-inflammatory activities of green tea catechins along the gut–liver axis in nonalcoholic fatty liver disease: lessons learned from preclinical and human studies,☆☆

https://doi.org/10.1016/j.jnutbio.2020.108478Get rights and content

Abstract

Nonalcoholic fatty liver disease (NAFLD), which is the most prevalent hepatic disorder worldwide, affecting 25% of the general population, describes a spectrum of progressive liver conditions ranging from relatively benign liver steatosis and advancing to nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. Hallmark features of NASH are fatty hepatocytes and inflammatory cell infiltrates in association with increased activation of hepatic nuclear factor kappa-B (NFκB) that exacerbates liver injury. Because no pharmacological treatments exist for NAFLD, emphasis has been placed on dietary approaches to manage NASH risk. Anti-inflammatory bioactivities of catechin-rich green tea extract (GTE) have been well-studied, especially in preclinical models that have detailed its effects on inflammatory responses downstream of NFκB activation. This review will therefore discuss the experimental evidence that has advanced an understanding of the mechanisms by which GTE, either directly through its catechins or potentially indirectly through microbiota-derived metabolites, limits NFκB activation and NASH-associated liver injury. Specifically, it will describe the hepatic-level benefits of GTE that attenuate intracellular redox distress and pro-inflammatory signaling from extracellular receptors that otherwise activate NFκB. In addition, it will discuss the anti-inflammatory activities of GTE on gut barrier function as well as prebiotic and antimicrobial effects on gut microbial ecology that help to limit the translocation of gut-derived endotoxins (e.g. lipopolysaccharides) to the liver where they otherwise upregulate NFκB activation by Toll-like receptor-4 signaling. This summary is therefore expected to advance research translation of the hepatic- and intestinal-level benefits of GTE and its catechins to help manage NAFLD-associated morbidity.

Abbreviations

ALT
alanine aminotransferase
AST
aspartate aminotransferase
CAT
catechins
EC
epicatechin
ECG
epicatechin gallate
EGC
epigallocatechin
EGCG
epigallocatechin gallate
FITC
fluorescein isothiocyanate
GSH
glutathione
GTE
green tea extract
HF
high-fat
HIF-1α
hypoxia inducible factor-1α
IΚΚ
IκB kinase
IκB
inhibitor of NFκB
iNOS
inducible nitric oxide synthase
LPS
lipopolysaccharides
MCD
methionine- and choline-deficient
MCP-1
monocyte chemoattractant protein-1
MyD88
myeloid differentiation primary response gene-88
NAFLD
nonalcoholic fatty liver disease
NASH
nonalcoholic steatohepatitis
NEFAs
non-esterified fatty acids
NFκB
nuclear factor kappa-B
Nrf2
nuclear factor erythroid 2-related factor-2
ROS
reactive oxygen species
TJPs
tight junction proteins
TLR4
Toll-like receptor-4
TNFα
tumor necrosis factor-α
TNFR
tumor necrosis factor-α receptor
TRIF
TIR-domain-containing adapter-inducing interferon-β
VL
valerolactones
WT
wild-type

Keywords

Green tea catechins
Nonalcoholic steatohepatitis
Inflammation
Metabolic endotoxemia
Gut dysbiosis

Cited by (0)

Support was provided by grants to RSB from USDA-NIFA (2019-67017-29259), the Center for Applied Plant Sciences at The Ohio State University, USDA-HATCH (OHO01452-MRF), and the Ohio Agricultural Research and Development Center at The Ohio State University.

☆☆

The authors declare no conflicts of interest.

View Abstract